Drug Trial Radar · NCT02689999
The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity
Last checked: Nov 20, 2026Latest source record: Aug 24, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Feb 2016
Primary completion
May 2017
Study completion Aug 2017
Sponsor
- Lead sponsor
- Neutec Ar-Ge San ve Tic A.ŞIndustry
- Sponsor type
- Industry
- First posted
- Feb 24, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
It is planned to investigate the effect of dexrabeprazole on gastric acid primarily, and then gastroesophageal reflux disease (GERD) symptoms, intraesophageal acidity (reflux) and impedance kinetics.
Conditions
- Gastroesophageal Reflux Disease (GERD)
Interventions
Dexrabeprazole 10 mg Enteric-Coated TabletsDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- - The percent of pH < 4 duration of 24-hour intragastric acidity and intraesophageal acidity after seven-days treatment.Time frame: One week
- - The area under curve (AUC) of pH < 4 duration of 24-hour intragastric acidity and intraesophageal acidity after seven-days treatment.Time frame: One week
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Ankara University Gastroenterology Department
Ankara, Turkey (Türkiye)
On Dokuz Mayıs University Gastroenterology Department
Samsun, Turkey (Türkiye)
Ege University Gastroenterology Department
Izmir, Bornova, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.